A long-term, observational cumulative registry study investigating the long-term efficacy and safety of testosterone undecanoate treatment in hypogonadal men: a real world study

Trial Profile

A long-term, observational cumulative registry study investigating the long-term efficacy and safety of testosterone undecanoate treatment in hypogonadal men: a real world study

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2017

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Hypogonadism
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 15 Sep 2017 Results (n=45) related to progression from prediabetes to type 2 diabetes were presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
    • 15 Sep 2017 Results on improvement in type 2 diabetes were presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
    • 04 Apr 2017 Results of analysis of cardivascular risk factor (anemia; n=505) presented at The 99th Annual Meeting of the Endocrine Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top